Found "Health Promotion": 927 results
Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Cetuximab is provided for mCRC patients with positive KRAS wild type, and also head and neck cancer patients as indicated in the Indonesian National Drug Formulary. However, currently, it is also used for indications not specified in the National Drug Formulary.
Adding cetuximab to chemothera
Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and P
Building Global Health Capacity for Countries in WHO South-East Asia Region
Global health is defined as health issues that transcend national boundaries. This notion implies a shared global responsibility for health and is associated with actors beyond country government. In WHO South-East Asia Region (SEAR), the Regional Committee adopted a resolution in 2010 to enco
Good Governance for Universal Health Coverage
Achieving universal health coverage (UHC) requires policy initiatives supported by long-term system reform and an accountable governance structure that can sustainably deliver all three dimensions of UHC, population coverage, breadth of benefits package, and degree of financial coverag
Budgeting and paying for services under Thailand’s Universal Coverage Scheme
Health financing is a component of the health system, crucial in achieving universal health coverage (UHC). Careful design of its three main functions, resource mobilisation, pooling and allocation, ensures improved access to essential health services and financial risk protection for
Evaluating the Value of a Real-World HTA Agency
As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about
Which investment on interventions against COVID-19 pandemic is worth its cost?
Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted
Unpacking Digital Health: A breakdown of concepts and definitions
Digital health is an umbrella term that includes all healthcare services that are provided by ICT. From one’s personal wearable devices to the use of big data and AI in healthcare come under digital health’
Under the umbrella of digital health technology, various sub-groups such as electronic
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed.
The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro
Kidney Replacement Therapy Policy of Universal Care Scheme in Thailand: Lessons Learned and The Way Forward
Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo
10 / Page